Salicylic Acid

Description

No description information is available.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by a rough, 'cauliflower-like' appearance on the surface, while plantar warts are specifically located on the bottom of the foot and may disrupt the normal footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and warts may be soaked in warm water for approximately 5 minutes to facilitate treatment. After soaking, the area must be dried completely. A small amount of the wart remover should be applied using the provided applicator, ensuring that each wart is sufficiently covered.

This application should be allowed to dry, and the procedure should be repeated once or twice daily. Treatment may continue until the wart is completely removed, with a maximum duration of up to 12 weeks.

Contraindications

Use is contraindicated in the following situations:

Patients with diabetes or poor blood circulation should not use this product, except under the advice and supervision of a healthcare professional, due to the increased risk of complications.

Application is not recommended on irritated, infected, or reddened skin, as this may exacerbate the condition.

The product should not be used on genital warts or warts located on the face, as these areas may require specialized treatment.

Additionally, it is contraindicated for use on moles, birthmarks, and warts with hair growing from them, due to the potential for adverse effects.

Finally, the product must not be applied to mucous membranes, as this could lead to irritation or other complications.

Warnings and Precautions

For external use only, this product is flammable and should be kept away from fire or flame. It is essential to cap the bottle tightly and store it at room temperature, away from heat sources.

This product is contraindicated for individuals with diabetes or poor blood circulation unless used under the advice and supervision of a healthcare professional, such as a doctor or podiatrist. It should not be applied to irritated, infected, or reddened skin, nor should it be used on genital warts, facial warts, moles, birthmarks, or warts with hair growing from them. Additionally, it must not be applied to mucous membranes.

When using this product, care should be taken to avoid contact with the eyes. In the event of contact, it is crucial to flush the eyes with water for at least 15 minutes. Inhalation of vapors should also be avoided to prevent respiratory irritation.

If discomfort persists after use, the patient should discontinue use and consult a healthcare professional. This product should be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Side Effects

Patients should be aware that this product is for external use only and is flammable; it should be kept away from fire or flame. The bottle must be tightly capped and stored at room temperature, away from heat sources.

The product should not be used by individuals who are diabetic or have poor blood circulation unless under the advice and supervision of a healthcare professional, such as a doctor or podiatrist. It is contraindicated for application on irritated, infected, or reddened skin, as well as on genital warts, warts on the face, moles, birthmarks, and warts with hair growing from them. Additionally, it should not be applied to mucous membranes.

While using this product, patients should avoid contact with the eyes. In the event that the product comes into contact with the eyes, it is recommended to flush the eyes with water for 15 minutes. Inhalation of vapors should also be avoided.

Patients are advised to discontinue use and consult a doctor if discomfort persists. Furthermore, this product should be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center should be made.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (wart remover liquid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients should be advised against the use of this product, particularly if they have diabetes or poor blood circulation, unless under the guidance and supervision of a qualified healthcare professional, such as a doctor or podiatrist. The safety of this product during pregnancy has not been established, and its use is contraindicated in specific populations due to potential risks.

Additionally, this product is intended for external use only, and pregnant patients should be cautioned to adhere strictly to this guideline to minimize any potential adverse effects on fetal outcomes. Healthcare providers should carefully evaluate the risks and benefits before recommending this product to women of childbearing potential.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects on lactation. Additionally, no data are provided concerning the excretion of this medication in breast milk or its potential effects on breastfed infants. Healthcare professionals should consider the lack of information when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are advised to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. In the event of swallowing the product, patients should seek medical help or contact a Poison Control Center immediately.

Patients should be informed that this product is not recommended for use in individuals with diabetes or poor blood circulation unless under the guidance and supervision of a healthcare professional, such as a doctor or podiatrist. It is also important to instruct patients not to apply the product on irritated, infected, or reddened skin, as well as on genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. Additionally, the product should not be used on mucous membranes.

Patients should be counseled to discontinue use and consult a doctor if discomfort persists after application. When using this product, it is crucial to avoid contact with the eyes; if the product does come into contact with the eyes, patients should flush them with water for at least 15 minutes. Furthermore, patients should be cautioned against inhaling vapors while using the product to minimize respiratory irritation.

Storage and Handling

The product is supplied in a tightly capped bottle. It is essential to store the bottle at room temperature, ensuring it is kept away from heat sources. The recommended storage temperature range is between 20°C to 30°C (68°F to 86°F). Additionally, it is crucial to keep the product away from fire or flame to maintain safety and integrity.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)